Prosight Management’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-192,700	Closed	-$10.2M	–	38
2024 Q3	$10.2M	Sell	192,700 -37,300	-16%	-$1.97M	2.5%	18
2024 Q2	$12.5M	Sell	230,000 -15,000	-6%	-$813K	3.72%	9
2024 Q1	$17.2M	Buy	+245,000	New	+$17.2M	4.78%	8